题  目：The Research and Development of Therapeutic Vaccines

主讲人：Zhongming Li

President of Shanghai Haigui Biotech Company

General Manager of Guan Dingtai-Haigui Biotech company

主持人：吴长有教授

中山医学院免疫学研究所 所长

时   间：2015年1月9日（星期五） 下午15:00时

地   点：中山大学北校区永生楼四楼讲学厅

主讲人简介：

Dr.Zhongming Li graduated from Fudan University Shanghai Medical College in 1970 and got his master degree of medical microbiology from Chinese Academy of Medical Sciences in 1982. He had his post-doctor training at the Center for Biologics Evaluation and Research of US FDA from 1986 to 1989 and then was employed by FDA as a research scientist from 1990 to 1999. He is now the president of Shanghai Haigui Biotech Company and the general manager of Guan Dingtai-Haigui Biotech company. He has been engaged in developing new vaccines including recombinant BCG and plasmid DNA against tuberculosis for more than 20 years. Preclinical studies on the immunotherapy of latent or multi-drug-resistant (MDR) tuberculosis, and therapeutic vaccines against tumor and cancer have become the focus of his research since 2009.